View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
November 24, 2021

Coronavirus company news summary – WHO and MPP sign deal with CSIC for Covid-19 antibody technology – South Korea’s Seegene to introduce new diagnostic tests 

By Kezia Parkins

The World Health Organization (WHO)’s Covid-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) have signed a licencing agreement for Spanish National Research Council’s (CSIC) Covid-19 serological antibody technology. The technology helps identify the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine. The agreement is expected to expedite the production and commercialisation of CSIC’s Covid-19 serological test worldwide and marks the first transparent, global, non-exclusive licence for a COVID-19 health tool, and the first test licence signed by MPP and included in the WHO Pool.

South Korean molecular diagnostics firm Seegene has announced it will introduce diagnostic tests in a move to better prepare for a potential increase in Covid-19 and influenza cases during the winter. The tests will be capable of identifying 22 targets including three Covid-19 genes in a single tube. This was announced alongside Seegene’s results for the third quarter of this year. The company reported sales revenue of KRW305.3bn ($260m) in the three-month period to 30 September 2021. The figure represents a 1% increase on a QoQ basis.

Vivera has introduced an AI software solution called LabPort to streamline the Covid-19 diagnostic testing process. The solution was created to enable immediate results reporting for diagnostic testing even in high-volume, field-based testing environments. It was first deployed in July 2021 and has been used to manage the testing process for more than 60,000 EUA-authorised rapid antigen and lab-based RT-PCR tests for major events.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network